SK

Sean Kendall

Partner at ARCH Venture Partners

London, England

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $50,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Chemical Engineering
Fermentation
Biofuels
Technology Transfer
Filtration
Renewable Chemicals
Molecular Biology
Molecular Cloning
Cell Culture
Biotechnology
Assay Development
High Throughput Screening
R&D
Laboratory
DNA
Protein Purification
Biochemistry
Analysis
Data Analysis
Research

Education

Lists including Sean

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

AIRNA

Series A

Total Funding: $90M

Moleculent

Series A

Total Funding: $26M

Protillion Biosciences

Series A

Total Funding: $18M

Work Experience

AV
ARCH Venture Partners

2015

  • Partner

    2022

  • Principal

    2021 - 2021

  • Senior Associate

    2018 - 2020

  • Associate

    2016 - 2018

  • Analyst

    2015 - 2016

Uo
University of Chicago Booth School of Business

2014 - 2016

  • MBA 2016 Candidate

    2014 - 2016

Cobalt Technologies

2013 - 2014

  • Process Engineer II

    2013 - 2014

LS9, Inc

2007 - 2012

  • Associate Process Engineer IV

    2010 - 2012

  • Senior Research Associate I, R&D

    2009 - 2010

  • Research Associate III

    2007 - 2009

Law Offices of Prescott J. Kendall

2002 - 2007

  • Legal Assistant

    2002 - 2007

    • Performed legal research, case organization, drafting and filing of state and federal court documents, and communication duties.

Swartz Lab, Stanford University

2006 - 2007

  • Research Assistant

    2006 - 2007

    • Researched biological catalysts for producing renewable hydrogen fuel using sunlight and water. • Successfully identified catalysts with improved resistance to oxygen poisoning.

Martin Lab, UCLA Medical Center

2004 - 2004

  • Laboratory Assistant

    2004 - 2004

    • Inflammatory bowel disease research. Performed RNA isolation, ribonuclease protection assay, luciferase expression assay, P32 labeling, ImageQuant analysis, and maintenance of mammalian cell lines.